arrow
W

Wayne G. Shreffler

massachusetts general hospital
H指数:59
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploratory Analyses of Predictors and Correlates of Response to Omalizumab Therapy in Patients with Multiple Food Allergies

对多食物过敏患者奥马珠单抗治疗反应的预测因子和相关因素的探索性分析

2025-11-120
OAAI
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy

多组学方法评估过敏原免疫疗法的个性化生物标志物

2025-09-040
OAAI
Introduction of allergenic foods after treatment with omalizumab

奥马珠单抗治疗后致敏性食物的引入

2025-05-280
PRE
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans

生殖系编码的识别机制是花生诱导人类抗体趋同发展的基础。

2025-01-010
OA
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
2025-01-011
PRE
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy

Dupilumab作为花生过敏患儿口服免疫治疗的辅助手段

2024-12-140
PRE
Immunomodulatory metabolites in IgE-mediated food allergy and oral immunotherapy outcomes based on metabolomic profiling

基于代谢组学分析的IgE介导的食物过敏和口服免疫治疗结果中的免疫调节代谢物

2024-11-122
PRE
TCF1-LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases

TCF1-LEF1共表达在人类过敏性疾病中鉴定多能祖细胞 (TH2-MPP)

2024-04-089
PRE
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy A Randomized Clinical Trial

在牛奶过敏的儿童中,使用Viaskin牛奶与安慰剂进行不同剂量的表皮免疫治疗随机临床试验

2024-04-014
OAAI
Omalizumab for the Treatment of Multiple Food Allergies

奥马珠单抗治疗多种食物过敏

2024-03-0774
PRE
Humoral profiles of toddlers and young children following SARS-CoV-2 mRNA vaccination
2024-01-302
OAAI